Cargando…
Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
Development of colorectal cancer occurs via a number of key pathways, with the clinicopathological features of specific subgroups being driven by underlying molecular changes. Mutations in key genes within the network of signalling pathways have been identified; however, therapeutic strategies to ta...
Autores principales: | Graham, Donna M., Coyle, Vicky M., Kennedy, Richard D., Wilson, Richard H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879165/ https://www.ncbi.nlm.nih.gov/pubmed/27340376 http://dx.doi.org/10.1007/s11888-016-0312-y |
Ejemplares similares
-
Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?
por: Coyle, Christopher, et al.
Publicado: (2016) -
Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer
por: Bernier, Laurence, et al.
Publicado: (2018) -
The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival
por: Brouwer, Nelleke P. M., et al.
Publicado: (2019) -
Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection
por: Ghiringhelli, Francois, et al.
Publicado: (2014) -
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
por: de Cuba, E. M. V., et al.
Publicado: (2016)